Kidwai Memorial Institute of Oncology

Kidwai Memorial Institute of Oncology (KMIO) is one of India's premier government-run cancer institutes and the largest dedicated oncology centre in South India. Located in Bangalore, Karnataka, the institute was established in 1973 and is named after Rafi Ahmed Kidwai, a prominent freedom fighter and independent India's first agriculture minister. The institute was conceived with the mission of providing comprehensive cancer care at affordable or no cost to patients from Karnataka, the broader South Indian region, and beyond.

With over 700 beds, KMIO handles tens of thousands of new cancer cases annually, making it one of India's highest-volume oncology institutions. The institute is affiliated with Rajiv Gandhi University of Health Sciences (RGUHS) and is an approved postgraduate training centre for oncology, surgery, medicine, and radiation physics, training India's next generation of cancer specialists.

KMIO is recognised by the Indian Council of Medical Research (ICMR) as a national cancer research centre and conducts active clinical research across all major cancer types. As a government institution, it provides free or heavily subsidised cancer treatment for economically disadvantaged patients under various state and national healthcare schemes, making advanced cancer care accessible to populations who would otherwise have no access. The institute's multidisciplinary approach — integrating surgical, medical, and radiation oncology with palliative care — mirrors international oncology practice standards.

Kidwai Memorial Institute of Oncology specialises exclusively in cancer care across all major tumour types and treatment modalities. Surgical Oncology covers head and neck cancers, breast cancer, thyroid and endocrine tumours, GI cancers (oesophagus, stomach, colon, rectal, liver, pancreatic, biliary), genitourinary cancers, gynaecological cancers (cervix, ovary, endometrium), sarcomas, and melanomas. Minimally invasive cancer surgery including laparoscopic resections and robotic-assisted procedures is available for select cases.

Medical Oncology provides inpatient and outpatient chemotherapy for solid tumours and haematological malignancies, targeted therapy, immunotherapy and checkpoint inhibitors for eligible cancers, and hormonal therapy for breast and prostate cancers. Bone marrow and peripheral blood stem cell transplantation (allogeneic and autologous) is performed for haematological cancers including acute leukaemia, lymphoma, and multiple myeloma.

Radiation Oncology offers external beam radiotherapy using linear accelerators with IMRT and 3D conformal RT capability, brachytherapy for gynaecological and head-neck tumours, stereotactic body radiotherapy (SBRT), and palliative radiation. Paediatric Oncology manages childhood cancers including acute leukaemia, Wilms tumour, neuroblastoma, retinoblastoma, Ewing sarcoma, and brain tumours with specialised protocols. Palliative Care and pain management services support quality of life throughout treatment and in advanced cancer stages.

KMIO is comprehensively equipped to deliver all components of modern cancer care. The Radiation Oncology department operates multiple linear accelerators (LINACs) capable of IMRT (intensity-modulated radiotherapy), 3D-CRT (3D conformal radiotherapy), image-guided radiotherapy (IGRT), and stereotactic body radiotherapy (SBRT). Brachytherapy units serve cervical and other gynaecological cancers. Treatment planning systems with CT simulation support precise radiation delivery.

The Bone Marrow Transplant Unit operates under strict isolation protocols with HEPA-filtered rooms for autologous and allogeneic transplantation. Surgical suites support all major oncological resections including complex gastrointestinal, thoracic, and head and neck surgeries. Operation theatres are equipped for endoscopic, laparoscopic, and open procedures.

Diagnostic capabilities include nuclear medicine imaging (gamma camera, PET-CT for staging and response assessment), MRI, CT, ultrasound, digital fluoroscopy, mammography, and CT-guided biopsy. A specialist onco-pathology laboratory handles histopathology, immunohistochemistry, molecular diagnostics (FISH, PCR), and cytology. The haematology and flow cytometry laboratory supports leukaemia and lymphoma diagnosis and monitoring. Blood bank and pharmacy services meet the intensive demands of oncology treatment including chemotherapy and supportive care medications. Outpatient chemotherapy day-care units reduce the need for prolonged inpatient stays for ambulatory chemotherapy regimens.

As a government-run institution, KMIO primarily serves Indian patients, particularly those from Karnataka, Tamil Nadu, Andhra Pradesh, Kerala, and other South Indian states. The institute is an important destination for patients from lower-income groups who cannot afford private hospital cancer treatment, providing care at highly subsidised costs or free of charge under government welfare schemes.

International patients from neighbouring South Asian countries including Bangladesh, Sri Lanka, Nepal, and Afghanistan, as well as from East Africa, do seek treatment at KMIO for its comprehensive oncology expertise and India's significantly lower cancer treatment costs compared to Western nations. Cancer treatment costs at KMIO, even for paying patients, are far below what equivalent care costs in the UK, US, or Europe, making it an attractive option for those seeking quality oncology care within budget.

The hospital administration office can assist international patients with appointment scheduling, specialist referral, and guidance on medical visa requirements. Communication is available in English, Kannada, Hindi, and Tamil. Accommodation options are available near the hospital campus in Bangalore. Patients are advised to contact the hospital administration directly at kidwai@kar.nic.in for pre-visit planning and appointment scheduling.

Kidwai Memorial Institute of Oncology is an Institute of National Importance under the Government of Karnataka and is recognised as a National Cancer Centre by the Indian Council of Medical Research (ICMR). ICMR recognition involves assessment of the institute's research capability, clinical quality, training infrastructure, and contribution to national cancer control programmes.

KMIO is affiliated with Rajiv Gandhi University of Health Sciences (RGUHS) and is an approved postgraduate training centre for MS, MD, MCh, and DM programmes in surgical, medical, and radiation oncology, as well as for allied health postgraduate courses. The institute participates in national multi-centre clinical trials conducted by the ICMR and collaborates with international cancer research networks. As a government institution, KMIO is subject to oversight by the Karnataka state health department and the central government Ministry of Health and Family Welfare. Clinical protocols are guided by national and international evidence-based oncology guidelines including those from the National Comprehensive Cancer Network (NCCN).